Anacor Pharmaceuticals, Inc.
Healthcare · Pharmaceutical Preparations · DE · SEC filings ↗ · Compare ⊕
Financials
SEC XBRL · annual| FY15 | FY14 | FY13 | FY12 | FY11 | FY10 | |
|---|---|---|---|---|---|---|
| Revenue | $15.3M | $4.2M | $17.2M | $10.7M | $20.3M | $27.8M |
| Operating income | −$56.4M | −$90.8M | $92.5M | −$53.2M | −$46.3M | −$9.5M |
| Net income | — | — | — | — | — | — |
| Total assets | $176.1M | $205.9M | $172.2M | $51.1M | $55.8M | $84.0M |
| Total liabilities | — | — | — | — | — | — |
| Equity | $52.3M | $78.8M | $121.4M | $4.8M | $13.9M | $56.4M |
| EPS (diluted) | $-1.39 | $-2.06 | $2.10 | $-1.76 | $-1.71 | $-2.71 |
| Shares out. | 43.4M | 41.8M | 36.1M | 31.5M | 28.2M | 28.0M |
Reported figures from the company's SEC filings (XBRL). Blank where a line item isn't cleanly tagged — never estimated.
Key ratios
from filings · FY2015- Operating margin
- −369.3%
- Net margin
- —
- Return on equity
- —
- Return on assets
- —
- Return on capital (ROCE)
- −38.5%
- Liabilities / assets
- —
- Debt / equity
- —
- Book value / share
- $1.20
- Revenue growth (YoY)
- 267.1%
- Net income growth (YoY)
- —
Computed from the company's own SEC figures — no market price, so these are facts, not a valuation. Book value per share is reported equity ÷ shares; it is not the stock price.
Quality score
EDS ScoreOur own multi-factor score from free SEC data — profitability, growth, financial strength, earnings quality, and event/ownership catalysts. No market price and no licensed model: each axis is the share of source-backed checks it passes. Descriptive factors, not advice or a forecast. What these scores mean →
Signs
● 2 warning● 1 good- Operating losses (negative operating margin)
- Negative operating cash flow
- Revenue is growing year-over-year
Derived from the company's own SEC figures (fundamentals, forensic scores, filing discipline) — descriptive factors, not advice or a forecast.
Material events
SEC Form 8-K · most recent- Completed an acquisition or disposition · Debt acceleration / triggering event · Delisting / listing-standard notice · Modified shareholder rights · Change in control · Director / officer change · Amended charter or bylaws · Other material eventJun 24, 2016
- Amended charter or bylaws · Shareholder voteJun 8, 2016
- Entered a material agreement · Regulation FD disclosureMay 16, 2016
- Results of operationsMay 10, 2016
- Entered a material agreement · New financial obligation · Unregistered equity saleApr 6, 2016
- Other material eventApr 1, 2016
- Other material eventMar 30, 2016
- Other material eventMar 22, 2016
Events the company reported on Form 8-K, labelled by the SEC item code it filed under — its own classification, not our interpretation.
Recent SEC filings
All filings ↗Event-driven situations (1)
Spot an error in this record? Report it. Every correction is verified against the source filing before we change anything.